Fig. 1
From: Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
Progression-free survival (a) and overall survival (b) Kaplan-Meier plot. Two patients came off-treatment before disease progression. They were censored at the off-treatment time point